期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
基于网络药理学和动物实验研究麝香通心滴丸防治糖尿病心肌病的作用机制 被引量:3
1
作者 白亚利 崔鑫钰 +4 位作者 袁悦莹 张雨婷 王伟 刘天华 吴晏 《中国中药杂志》 CAS CSCD 北大核心 2024年第7期1905-1914,共10页
通过网络药理学、分子对接及动物实验探究麝香通心滴丸(Shexiang Tongxin Dropping Pills,STDP)防治糖尿病心肌病(diabetic cardiomyopathy,DCM)的作用机制。借助BATMAN、TCMSP、GeneCards等数据库筛选STDP防治DCM的活性成分及作用靶点... 通过网络药理学、分子对接及动物实验探究麝香通心滴丸(Shexiang Tongxin Dropping Pills,STDP)防治糖尿病心肌病(diabetic cardiomyopathy,DCM)的作用机制。借助BATMAN、TCMSP、GeneCards等数据库筛选STDP防治DCM的活性成分及作用靶点,利用STRING数据库及Cytoscape软件构建STDP防治DCM作用靶点的蛋白-蛋白相互作用(protein-protein inte-raction,PPI)网络及“药物-活性成分-靶点”网络,通过DAVID数据库对作用靶点进行GO和KEGG富集分析,采用AutoDock Vina软件对关键信号通路核心受体蛋白与其对应活性成分进行分子对接验证。采用高脂喂养联合腹腔注射链脲佐菌素的方法建立DCM大鼠模型,分为对照组、模型组、STDP低剂量组(20 mg·kg^(-1))、STDP高剂量组(40 mg·kg^(-1))、二甲双胍组(200 mg·kg^(-1));连续给药8周后超声心动图检测各组大鼠心功能,苏木精-伊红(hematoxylin-eosin,HE)染色观察各组大鼠心肌病理改变,天狼猩红染色检测各组大鼠心肌胶原纤维沉积,WGA染色检测心肌肥大程度,蛋白免疫印迹法检测各组大鼠心肌组织中p38丝裂原活化蛋白激酶(p38 mitogen-activated protein kinase,p38)、磷酸化p38(phosphorylation-p38,p-p38)、c-Jun氨基末端激酶(c-Jun N-terminal kinase,JNK)、磷酸化JNK(phosphorylation-JNK,p-JNK)、caspase-3及C-caspase-3蛋白的表达。网络药理学筛选得到STDP活性成分199种,对应靶点1655个,与463个DCM疾病靶点取交集,得到134个STDP防治DCM的潜在作用靶点,并筛选出糖尿病并发症中的AGE-RAGE信号通路;分子对接结果显示miltirone、dehydromiltirone和tryptanthrin与RAGE均有较好的结合力。动物实验结果证实,STDP可有效保护DCM大鼠心功能,与模型组比较,STDP低、高剂量组p-p38、p-JNK、C-caspase-3蛋白表达水平均显著降低。综上,SDTP可能通过影响AGE-RAGE信号通路发挥对DCM大鼠心功能的保护作用。 展开更多
关键词 麝香通心滴丸 糖尿病心肌病 网络药理学 分子对接 动物实验 AGE-RAGE信号通路 心功能
原文传递
Shexiang Tongxin Dropping Pill Promotes Angiogenesis through VEGF/eNOS Signaling Pathway on Diabetic Coronary Microcirculation Dysfunction 被引量:1
2
作者 CUI Xin-yu LIU Tian-hua +8 位作者 BAI Ya-li ZHANG Meng-di LI Guo-dong ZHANG Yu-ting yuan yue-ying ZHANG Ya-wen YU Li-shuang HAN Li-na WU Yan 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2024年第10期886-895,共10页
Objective:To study the effect of Shexiang Tongxin Dropping Pill(STDP)on angiogenesis in diabetic cardiomyopathy mice with coronary microcirculation dysfunction(CMD).Methods:According to a random number table,6 of 36 S... Objective:To study the effect of Shexiang Tongxin Dropping Pill(STDP)on angiogenesis in diabetic cardiomyopathy mice with coronary microcirculation dysfunction(CMD).Methods:According to a random number table,6 of 36 SPF male C57BL/6 mice were randomly selected as the control group,and the remaining 30 mice were injected with streptozotocin intraperitoneally to replicate the type 1 diabetes model.Mice successfully copied the diabetes model were randomly divided into the model group,STDP low-dose group[15 mg/(kg·d)],medium-dose group[30 mg/(kg·d)],high-dose group[60 mg/(kg·d)],and nicorandil group[15 mg/(kg·d)],6 in each group.The drug was given by continuous gavage for 12 weeks.The cardiac function of mice in each group was detected at the end of the experiment,and coronary flow reserve(CFR)was detected by chest Doppler technique.Pathological changes of myocardium were observed by hematoxylin-eosin staining,collagen fiber deposition was detected by masson staining,the number of myocardial capillaries was detected by platelet endothelial cell adhesion molecule-1 staining,and the degree of myocardial hypertrophy was detected by wheat germ agglutinin staining.The expression of the vascular endothlial growth factor(VEGF)/endothelial nitric oxide synthase(eNOS)signaling pathway-related proteins in myocardial tissue was detected by Western blot.Results:Compared with the model group,medium-and high-dose STDP significantly increased the left ventricular ejection fraction and left ventricular fraction shortening(P<0.01),obviously repaired the disordered cardiac muscle structure,reduced myocardial fibrosis,reduced myocardial cell area,increased capillary density,and increased CFR level(all P<0.01).Western blot showed that high-dose STDP could significantly increase the expression of VEGF and promote the phosphorylation of vascular endothelial growth factor receptor 2,phosphoinositide 3-kinase,protein kinase B,and eNOS(P<0.05 or P<0.01).Conclusion:STDP has a definite therapeutic effect on diabetic CMD,and its mechanism may be related to promoting angiogenesis through the VEGF/eNOS signaling pathway. 展开更多
关键词 Shexiang Tongxin Dropping Pill type 1 diabetes diabetic cardiomyopathy coronary microcirculation dysfunction ANGIOGENESIS
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部